MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

G Marconi, A Talami, MC Abbenante… - European Journal of …, 2020 - Wiley Online Library
Introduction Clinical response and chemosensitivity of relapse or refractory AML patients
were evaluated after rescue and bridge‐to‐transplant MEC (mitoxantrone, etoposide, and …
被引用次数：6 相关文章

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

G Marconi, A Talami, MC Abbenante, C Sartor… - EUROPEAN JOURNAL …, 2020 - iris.unito.it
Introduction: Clinical response and chemosensitivity of relapse or refractory AML patients
were evaluated after rescue and bridge-to-transplant MEC (mitoxantrone, etoposide, and …

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.

G Marconi, A Talami, MC Abbenante… - European Journal of …, 2020 - europepmc.org
Results 27/55 patients (49.1%) had AML resistant to induction and 28/55 patients (50.9%)
had AML relapse. 25/55 patients (45.5%) achieved a CR after one course of MEC, and 12 …

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.

G Marconi, A Talami, MC Abbenante… - European Journal …, 2020 - search.ebscohost.com
Introduction: Clinical response and chemosensitivity of relapse or refractory AML patients
were evaluated after rescue and bridge‐to‐transplant MEC (mitoxantrone, etoposide, and …

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

G Marconi, A Talami, MC Abbenante… - European journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Clinical response and chemosensitivity of relapse or refractory AML patients
were evaluated after rescue and bridge-to-transplant MEC (mitoxantrone, etoposide, and …

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

G Marconi, A Talami, MC Abbenante, C Sartor… - EUROPEAN JOURNAL …, 2020 - cris.unibo.it
Introduction: Clinical response and chemosensitivity of relapse or refractory AML patients
were evaluated after rescue and bridge-to-transplant MEC (mitoxantrone, etoposide, and …